Meizhu Wu

机构：Fujian University of Traditional Chinese Medicine, Hainan Normal University, Integrative Medicine Institute, Center for Innovation · ORCID：0000-0003-2010-8644

发表论文 77 篇 · 总被引 737 次 · h-index 17

代表论文

• Baicalin alleviates angiotensin II‐induced cardiomyocyte apoptosis and autophagy and modulates the AMPK/mTOR pathway (2024 · Journal of Cellular and Molecular Medicine · 被引 33)
• Enhancing the therapeutic potential of isoliensinine for hypertension through PEG-PLGA nanoparticle delivery: A comprehensive in vivo and in vitro study (2024 · Biomedicine & Pharmacotherapy · 被引 18)
• Dehydrocorydaline attenuates myocardial ischemia-reperfusion injury via the FoXO signalling pathway: A multimodal study based on network pharmacology, molecular docking, and experimental study (2024 · Journal of Ethnopharmacology · 被引 14)
• Qing Hua Chang Yin ameliorates chronic colitis in mice by inhibiting PERK–ATF4–CHOP pathway of ER stress and the NF-κB signalling pathway (2024 · Pharmaceutical Biology · 被引 6)
• Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway (2024 · Chinese Journal of Integrative Medicine · 被引 6)
• Neferine attenuates hypertensive cardiomyocyte apoptosis and modulates key signaling pathways: An in vivo and in vitro study (2025 · European Journal of Pharmacology · 被引 5)